United Therapeutics Corporation
UTHR Healthcare Drug Manufacturers Specialty & Generic
United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024. In the quarter to June 2026, revenue fell 1.92%, EPS grew 14.0% and free cash flow grew 58.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow UTHR
United Therapeutics Corporation (UTHR) P/E ratio
As of 16 October 2026, United Therapeutics Corporation (UTHR) trades at a P/E ratio of 17.6×. Over the past ten years it has ranged from 0.0× (March 2020) to 48.4× (July 2015); the current reading is higher than 83% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 16.1× | 21.03% |
| FY2024 | 13.3× | 23.57% |
| FY2023 | 10.8× | (36.77%) |
| FY2022 | 17.1× | (16.33%) |
| FY2021 | 20.4× | 56.60% |
| FY2020 | 13.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 8.0× | (49.57%) |
| FY2017 | 15.9× | 78.62% |
| FY2016 | 8.9× | (18.95%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 17.9× | (11.52%) |
| Mar 2026 | 20.2× | 25.27% |
| Dec 2025 | 16.1× | 9.80% |
| Sep 2025 | 14.7× | 41.80% |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| VTRS Viatris Inc. compare | n/m |
| ELAN Elanco Animal Health Incorporated compare | n/m |
| ZTS Zoetis Inc. compare | 13.0× |
| UTHR United Therapeutics Corporation | 17.6× |
| NBIX Neurocrine Biosciences, Inc. compare | 19.2× |
| HLN Haleon PLC Sponsored ADR compare | 22.6× |
| TAK Takeda Pharmaceutical Co. compare | 29.6× |
| RDY Dr. Reddy's Laboratories Ltd compare | 32.9× |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 65.9× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)